Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NELFCD and CTSZ loci are associated with jaundice-stage progression in primary biliary cholangitis in the Japanese population.
Nishida N, Aiba Y, Hitomi Y, Kawashima M, Kojima K, Kawai Y, Ueno K, Nakamura H, Yamashiki N, Tanaka T, Tamura S, Mori A, Yagi S, Soejima Y, Yoshizumi T, Takatsuki M, Tanaka A, Harada K, Shimoda S, Komori A, Eguchi S, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M. Nishida N, et al. Among authors: komori a. Sci Rep. 2018 May 23;8(1):8071. doi: 10.1038/s41598-018-26369-6. Sci Rep. 2018. PMID: 29795304 Free PMC article.
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, Daikoku M, Yano K, Matsumoto T, Migita K, Yatsuhashi H, Ito M, Masaki N, Adachi H, Watanabe Y, Nakamura Y, Saoshiro T, Sodeyama T, Koga M, Shimoda S, Ishibashi H. Nakamura M, et al. Among authors: komori a. J Hepatol. 2005 Mar;42(3):386-92. doi: 10.1016/j.jhep.2004.11.016. J Hepatol. 2005. PMID: 15710222
Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.
Takii Y, Nakamura M, Ito M, Yokoyama T, Komori A, Shimizu-Yoshida Y, Nakao R, Kusumoto K, Nagaoka S, Yano K, Abiru S, Ueki T, Matsumoto T, Daikoku M, Taniguchi K, Fujioka H, Migita K, Yatsuhashi H, Nakashima M, Harada M, Ishibashi H. Takii Y, et al. Among authors: komori a. Lab Invest. 2005 Jul;85(7):908-20. doi: 10.1038/labinvest.3700285. Lab Invest. 2005. PMID: 15856047 Free article.
Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways.
Yokoyama T, Komori A, Nakamura M, Takii Y, Kamihira T, Shimoda S, Mori T, Fujiwara S, Koyabu M, Taniguchi K, Fujioka H, Migita K, Yatsuhashi H, Ishibashi H. Yokoyama T, et al. Among authors: komori a. Liver Int. 2006 May;26(4):467-76. doi: 10.1111/j.1478-3231.2006.01254.x. Liver Int. 2006. PMID: 16629651
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, Daikoku M, Abiru S, Yatsuhashi H, Takezaki E, Masaki N, Sugi K, Honda K, Adachi H, Nishi H, Watanabe Y, Nakamura Y, Shimada M, Komatsu T, Saito A, Saoshiro T, Harada H, Sodeyama T, Hayashi S, Masumoto A, Sando T, Yamamoto T, Sakai H, Kobayashi M, Muro T, Koga M, Shums Z, Norman GL, Ishibashi H. Nakamura M, et al. Among authors: komori a. Hepatology. 2007 Jan;45(1):118-27. doi: 10.1002/hep.21472. Hepatology. 2007. PMID: 17187436
Guidelines for therapy of autoimmune liver disease.
Ishibashi H, Komori A, Shimoda S, Gershwin ME. Ishibashi H, et al. Among authors: komori a. Semin Liver Dis. 2007 May;27(2):214-26. doi: 10.1055/s-2007-979472. Semin Liver Dis. 2007. PMID: 17520519
376 results